Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Expression of Concern

Expression of Concern: TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma

  • The PLOS One Editors

The PLOS One Editors issue this Expression of Concern because this article [1] was identified as one of a series of submissions for which we have concerns about the peer review process. Readers are advised to interpret the article [1] with caution.

The Editors have no evidence of any author involvement in the peer review concerns.

Additionally, after this article [1] was published, the following concerns were noted:

  • The article cited as Reference 2 was retracted after [1] was accepted for publication and before [1] was published.
  • The article cited as Reference 8 was retracted after [1] was published.

Reference

  1. 1. Shi K, Liu X-L, Guo Q, Zhang Y-Q, Fan S-T, Dai L, et al. TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma. PLoS One. 2023;18(7):e0285817. pmid:37478120

Citation: The PLOS One Editors (2026) Expression of Concern: TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma. PLoS One 21(4): e0348229. https://doi.org/10.1371/journal.pone.0348229

Published: April 29, 2026

Copyright: © 2026 The PLOS One Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.